POPULAR SEARCHES
betadine-dry-powder-spray
Wound-additional-pic

BETADINE®
Dry Powder Spray
PVP-I 2.5%

PREVENT INFECTION BURNS CUTS
  • Wide spectrum antiseptic recommended for the prevention of infection in wounds, including ulcers, burns, cuts and other minor injuries.
  • Broad-spectrum microbicidal action
  • Fast action: kills microbes within 30 seconds of application
  • Portable format, easy to carry
PRESCRIBING INFORMATION

How to use?

Betadine-Dry-Powder-Spray-Step-1

1

Clean the affected area with an
antiseptic such as BETADINE®
Antiseptic Solution (Contains Povidone-Iodine 10%w/v).1

dry-powder-spray-step-2

2

Spray BETADINE® Dry Powder
Spray on the affected area at a
distance of 6-10 inches away.1

dry-powder-spray-step-3

3

Cover with plaster or wound
dressing as necessary. 1

dry-powder-spray-step-3

4

Repeat BETADINE® Dry powder
spray can be applied every 3-4
hours 1

RELATED PRODUCTS

LEARN MORE
betadine-antiseptic-solution-pvpi-10

BETADINE® Antiseptic Solution PVP-I 10%

LEARN MORE
betabetadine-antiseptic-ointment-pvpi-10-with-box

BETADINE® Antiseptic Ointment PVP-I 10%

WHERE TO BUY

Shop online

Shop products online

Shop in store

Locate a partner store near you

REFERENCES

  1. BETADINE® 2.5% Dry Powder Spray Local Package Insert Leaflet
  2. Mayer DA, et al. Povidone-Iodine and wound healing: A Critical Review. Wounds: A Compendium of Clinical Research and Practice. 1993; 5(1): 14-23.
  3. Remington “The Science & Practice of Pharmacy” 20th Ed, William K.Nichols, PhD. Anti-Infectives. Chapter 87-1516
  4. Fleischer W, Reimer K. Povidone Iodine: in antisepsis-State of Art. Dermatology 1997;195 (suppl 2):3-9
  5. Saggers BA, Stewart GT. Polyvinyl-pyrrolidone-iodine: an assessment of antibacterial activity. J Hyg. 1964; 62: 509-518
  6. Plotkin SA. Medical and Surgical Antisepsis with BETADINE®. Microbicides. New York;The Purdue Frederick Company. 1972:9-16
  7. Reimer K, Schreier H, Erdos G, Konig W, Fleischer W. Molecular effects of a microbicidal substance on relevant microorganisms: electron microscopic and biochemical studies on Povidone-iodine. Zentralbi Hyg Umweltmed. 1998 Feb; 200(5-6):423-34.
  8. Russel, AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrobiol Chemo (2003) 52, 750-763.
  9. Rutala W, Weber D. The Healthcare Infection Control Practices Advisory Committee (HICPAC)
  10. Mcdonnell G, Russell AD. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev. Jan. 1999. 147-179.
  11. Eming SA, et al. A novel property of povidone-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J In Dermatol (2006) 126, 2731-2733.
  12. Kunisada T,Yamada K, Oda S and Hara O. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 1997; 195(suppl 2): 14-18.
  13. Lachapelle J, Castel O, et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin. Pract. (2013) 10(5), 579-592.
  14. Hand, Foot and Mouth Disease Information Sheet. World Health Organization (Western Pacific Region). Available at http://www.wpro.who.int/emerging_diseases/hfmd.information.sheet/en. Accessed on 29/11/2016.
  15. Leyden J., Stewart R., et al. Updated in vivo Methods for Evaluating Topical Antimicrobial Agents on Human Skin. The Journal of Investigative Dermatology, Vol 72(4): 165-170, 1979

CONTRAINDICATIONS

  • BETADINE® Dry Powder Spray is contraindicated for patients with hypersensitivity to iodine, hyperthyroidism.
  • Not to be used in children under 2 years of age.
  • During pregnancy and lactation, BETADINE® Dry Powder Spray should only be used if strictly prescribed by a doctor and its use should be kept to an absolute minimum.

Please report any suspected Mundipharma Product or Device related adverse event or product complaint to: meadrugsafety@mundipharma.ae or contact +971 4 439 8777.

Consult your doctor / pharmacist before taking pharmaceutical products